Editorial: Treatment response and resistance to targeted therapies for NSCLC.
APA
Wei S, Wei Z, et al. (2026). Editorial: Treatment response and resistance to targeted therapies for NSCLC.. Frontiers in oncology, 16, 1780209. https://doi.org/10.3389/fonc.2026.1780209
MLA
Wei S, et al.. "Editorial: Treatment response and resistance to targeted therapies for NSCLC.." Frontiers in oncology, vol. 16, 2026, pp. 1780209.
PMID
41971417
같은 제1저자의 인용 많은 논문 (5)
- Effect of electroacupuncture on postoperative delirium in elderly patients undergoing laparoscopic radical prostatectomy: study protocol for a double-center randomized controlled trial.
- Biliary disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database.
- Profiling of the Golgi Apparatus Proteome in Living Cells Using Nanophotosensitizer-Mediated Photocatalytic Proximity Labeling.
- Discovery and Validation of Lung Cancer Biomarkers Based on Proteomic Analysis of Bronchoalveolar Lavage Fluid from the Self-Controlled Pulmonary Lobes.
- Endoplasmic reticulum stress in disease pathogenesis: its implications for therapy.